Inari CEO Ponsi Trivisvavet was formerly the chief operating officer of another agriculture-tech startup launched by Flagship in 2013, Indigo Agriculture. Inari Agriculture.

Corteva is suing seed startup Inari for intellectual property theft, alleging in a lawsuit filed in federal court Wednesday that Inari tweaked biotech traits in Corteva’s seeds and is now trying ...

IRVINE, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering ...

V ascular device maker Inari Medical announced plans to buy LimFlow, a company selling a last-line therapy to save legs with blocked blood flow, on Wednesday. Inari will pay $250 million upfront ...

Stryker (SYK) confirmed an agreement to purchase Inari Medical (NASDAQ:NARI) for about $4.9 billion. Inari jumped 21% in after hours trading. The medical devices firm will play $80 a share in cash ...

Inari Agriculture, a biotechnology company developing next-generation seeds, has secured $145 million since its founding less than four years ago and is expanding its operations at its Purdue Research ...

The logo and trading info for Corteva Agriscience, a former division of DowDuPont, is displayed on a screen at the New York Stock Exchange (NYSE) in New York, U.S., June 3, 2019.

Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. In the first quarter, the fund ...

The medical device maker plans to buy all of Inari’s common stock for $80 a share, representing a total fully diluted equity value of about $4.9 billion.

Stryker will acquire Inari for $80 per share—a price Inari shares were last at in late 2022. The deal values the company at roughly $4.9 billion, the companies said.

Seed technology startup Inari has reached $1.5 billion valuation after raising $124 million in fresh financing. The Cambridge, Massachusetts-based company’s funding round includes new investor ...

Inari Medical has raised $27 million to support commercialization of devices for removing large clots from big vessels. New investor Gilde Healthcare led the round with the support of Versant ...